SERPING1 Reduces Cell Migration via ERK ‐ MMP2 ‐ MMP ‐9 Cascade in Sorafenib‐ Resistant Hepatocellular Carcinoma
Environmental Toxicology · 2025
DOI: 10.1002/tox.24434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, 2025. Verfasst von Ching-Chuan Hsieh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Surgery, Chang Gung Memorial Hospital, Chiayi, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Sorafenib, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Cheng Kung University Hospital, Chang Gung Memorial Hospital.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is the most common primary hepatic malignant tumor, and it ranks 2nd in terms of mortality rate among all malignancies in Taiwan. Sorafenib is a multiple tyrosine kinase inhibitor that suppresses tumor cell proliferation and angiogenesis around tumors via different pathways. However, the survival outcome of advanced HCC patients treated with sorafenib is still unsatisfactory. Unfortunately, there are no clinically applicable biomarkers to predict sorafenib therapeutic efficiency in HCC thus far. We found that serpin peptidase inhibitor, clade G, member 1 (SERPING1) is highly associated with overall and recurrence‐free survival rates in HCC patients and is also highly correlated with several clinical parameters. SERPING1 expression was increased with sorafenib in both the HCC cell extract and conditioned medium, which was also observed in sorafenib‐resistant HepG2 and Huh7 cells. Sorafenib decreased cell viability and migration, which was similar to the effect of SERPING1 in HCC progression. Moreover, sorafenib inhibited both MMP‐2 and MMP‐9 activity and enhanced the expression of p‐ERK in HCC cells. In summary, sorafenib reduces HCC cancer progression might through the p‐ERK‐MMP‐2‐MMP‐9 cascade via upregulation of SERPING1. In the present study, the roles and molecular mechanisms of SERPING1 and its value as a marker for predicting sorafenib resistance and progression in HCC patients were examined. The results of the present study provide a deep understanding of the roles of SERPING1 in HCC sorafenib resistance, which can be applied to develop early diagnosis and prognosis evaluation methods and establish novel therapeutic targets for specifically treating HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of General Surgery, Chang Gung Memorial Hospital, Chiayi, Taiwan.
- Department of Cell Biology and Anatomy, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
- Department of Biochemistry, School of Medicine, China Medical University, Taichung, Taiwan.
- Department of General & Gastroenterological Surgery, An Nan Hospital, China Medical University, Tainan, Taiwan.
- Liver Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- Department of Biochemistry, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
ORCID-Profile: Cheng-Yi Chen
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Cheng Kung University Hospital
- Chang Gung Memorial Hospital
- An Nan Hospital, China Medical University
- Tainan Municipal An-Nan Hospital
Zitieren
APA
Hsieh, C. C., Wu, Y. H., Chen, Y. L., Wang, C. I., Li, C. J., Liu, I. H., Chou, C. W., Lin, Y. H., Huang, P. S., Huang, T. C., & Chen, C. Y. (2025). SERPING1 Reduces Cell Migration via ERK ‐ MMP2 ‐ MMP ‐9 Cascade in Sorafenib‐ Resistant Hepatocellular Carcinoma. Environmental Toxicology. https://doi.org/10.1002/tox.24434
Vancouver
Hsieh CC, Wu YH, Chen YL, Wang CI, Li CJ, Liu IH, et al. SERPING1 Reduces Cell Migration via ERK ‐ MMP2 ‐ MMP ‐9 Cascade in Sorafenib‐ Resistant Hepatocellular Carcinoma. Environmental Toxicology. 2025. doi:10.1002/tox.24434
BibTeX
@article{Hsieh2025,
author = {Hsieh, Ching-Chuan and Wu, Yuh-Harn and Chen, Yi-Li and Wang, Chun-I and Li, Chao-Jen and Liu, I-Hsiu and Chou, Chen-Wei and Lin, Yang-Hsiang and Huang, Po-Shuan and Huang, Te-Chia and Chen, Cheng-Yi},
title = {SERPING1 Reduces Cell Migration via ERK ‐ MMP2 ‐ MMP ‐9 Cascade in Sorafenib‐ Resistant Hepatocellular Carcinoma},
journal = {Environmental Toxicology},
year = {2025},
doi = {10.1002/tox.24434}
}
EUVIMED